1-deoxynojirimycin has been researched along with Di Guglielmo Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Den Otter, W; Dullens, HF; Vliegenthart, JF; Voshol, H | 1 |
Broxterman, HJ; Lindhout, J; Neefjes, JJ; Ploegh, HL; van Boom, JH; van der Marel, GA | 1 |
Broxterman, HJ; Neefjes, JJ; Ploegh, HL; van Boom, JH; van der Marel, GA; Verkerk, JM | 1 |
3 other study(ies) available for 1-deoxynojirimycin and Di Guglielmo Disease
Article | Year |
---|---|
Cell surface glycoconjugates as possible target structures for human natural killer cells: evidence against the involvement of glycolipids and N-linked carbohydrate chains.
Topics: 1-Deoxynojirimycin; Carbohydrate Conformation; Carbohydrate Metabolism; Carbohydrates; Cell Membrane; Flow Cytometry; Glycoconjugates; Glycolipids; Glycosylation; Humans; Killer Cells, Natural; Lectins; Leukemia, Erythroblastic, Acute; Membrane Proteins; N-Acetylneuraminic Acid; Neoplasms; Neuraminidase; Sialic Acids; Trypsin; Tumor Cells, Cultured | 1993 |
Non-carrier-mediated uptake of the mannosidase I inhibitor 1-deoxymannojirimycin by K562 erythroleukemic cells.
Topics: 1-Deoxynojirimycin; Biological Transport; Cell Line; Glucosamine; Glucose; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mannose; Mannosidases; Tritium | 1989 |
Recycling glycoproteins do not return to the cis-Golgi.
Topics: 1-Deoxynojirimycin; Anti-Bacterial Agents; Carcinoma, Hepatocellular; Cell Line, Transformed; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Glucosamine; Glycoproteins; Golgi Apparatus; HLA Antigens; HLA-D Antigens; Humans; Immunoassay; Isoelectric Focusing; Leukemia, Erythroblastic, Acute; Liver Neoplasms; Mannosidases; Neuraminidase; Receptors, Transferrin; Transferrin; Tumor Cells, Cultured | 1988 |